{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T04:58:13Z","timestamp":1785128293537,"version":"3.55.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005053","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Bioingenier\u00eda, Biomateriales y Nanomedicina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["964264"],"award-info":[{"award-number":["964264"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2021 SGR 01173"],"award-info":[{"award-number":["2021 SGR 01173"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jconrel.2025.113616","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T03:28:46Z","timestamp":1741577326000},"page":"113616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Preclinical evaluation of several polymeric micelles identifies Soluplus\u00ae-docetaxel as the most effective candidate in multiple glioblastoma models"],"prefix":"10.1016","volume":"381","author":[{"given":"J\u00falia","family":"German-Cort\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Torroglosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Pumarola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narine","family":"Fischer-Albiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Campos-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Sabat\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c0ngels","family":"Alcina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Mancilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monserrat","family":"Llaguno-Munive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zamira V.","family":"D\u00edaz-Riascos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Sim\u00f3","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roser","family":"Ferrer-Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibane","family":"Abasolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"S\u00e1nchez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Rafael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jconrel.2025.113616_bb0005","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-oncology"},{"issue":"5","key":"10.1016\/j.jconrel.2025.113616_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25053040","article-title":"Glioblastoma: An update in pathology, molecular mechanisms and biomarkers","volume":"25","author":"Lan","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.113616_bb0015","series-title":"StatPearls","article-title":"Glioblastoma multiforme","author":"Kanderi","year":"2025"},{"issue":"7","key":"10.1016\/j.jconrel.2025.113616_bb0020","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jama.2023.0023","article-title":"Glioblastoma and other primary brain malignancies in adults: a review","volume":"329","author":"Schaff","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jconrel.2025.113616_bb0025","article-title":"Glioblastoma: clinical presentation, diagnosis, and management","volume":"374","author":"McKinnon","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113616_bb0030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13046-022-02349-7","article-title":"Emerging therapies for glioblastoma: current state and future directions","volume":"41","author":"Rong","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.jconrel.2025.113616_bb0035","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncology"},{"issue":"7","key":"10.1016\/j.jconrel.2025.113616_bb0040","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/sj.bjc.6603669","article-title":"Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di neuro-Oncologia (GICNO)","volume":"96","author":"Franceschi","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113616_bb0045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/ajns.AJNS_95_17","article-title":"Significant effect of anti-tyrosine kinase inhibitor (Gefitinib) on overall survival of the glioblastoma multiforme patients in the backdrop of mutational status of epidermal growth factor receptor and","volume":"13","author":"Arif","year":"2018","journal-title":"Asian J. Neurosurg."},{"issue":"17","key":"10.1016\/j.jconrel.2025.113616_bb0050","doi-asserted-by":"crossref","first-page":"21722","DOI":"10.1021\/acsami.4c04289","article-title":"Overcoming the blood-brain tumor barrier with docetaxel-loaded mesoporous silica nanoparticles for treatment of Temozolomide-resistant glioblastoma","volume":"16","author":"Hsu","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"12","key":"10.1016\/j.jconrel.2025.113616_bb0055","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1007\/s13346-024-01659-x","article-title":"Chemical engineering of zein with polyethylene glycol and Angiopep-2 to manufacture a brain-targeted docetaxel nanomedicine for glioblastoma treatment","volume":"14","author":"Awad","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"issue":"24","key":"10.1016\/j.jconrel.2025.113616_bb0060","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.21037\/atm-22-2670","article-title":"Effects of postoperative radiotherapy and docetaxel and PD-1 inhibitors on the survival and safety of glioblastoma patients: a systematic review and meta-analysis","volume":"10","author":"Fan","year":"2022","journal-title":"Ann. Transl. Med."},{"issue":"10","key":"10.1016\/j.jconrel.2025.113616_bb0065","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41568-022-00496-9","article-title":"Cancer nanomedicine","volume":"22","author":"Bhatia","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113616_bb0070","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/21655979.2021.2012907","article-title":"New challenges in the use of nanomedicine in cancer therapy","volume":"13","author":"Rasool","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.jconrel.2025.113616_bb0075","series-title":"Nanooncology","article-title":"Micellar-based nanoparticles for cancer therapy and bioimaging","author":"Andrade","year":"2018"},{"key":"10.1016\/j.jconrel.2025.113616_bb0080","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2021.01.022","article-title":"Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo","volume":"331","author":"Andrade","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113616_bb0085","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ijpharm.2019.05.033","article-title":"Nonionic surfactants modulate the transport activity of ATP-binding cassette (ABC) transporters and solute carriers (SLC): relevance to oral drug absorption","volume":"566","author":"Al-Ali","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.jconrel.2025.113616_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12101000","article-title":"Physicochemical, pharmacokinetic, and toxicity evaluation of Soluplus","volume":"12","author":"Jin","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113616_bb0095","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.biopha.2014.12.028","article-title":"Soluplus(\u00ae) micelles as a potential drug delivery system for reversal of resistant tumor","volume":"69","author":"Jin","year":"2015","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113616_bb0100","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0022-3565(24)29254-5","article-title":"Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization","volume":"299","author":"Batrakova","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113616_bb0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3847\/1538-3881\/ab2634","article-title":"Marvin: a tool kit for streamlined access and visualization of the SDSS-IV MaNGA data set","volume":"158","author":"Cherinka","year":"2019","journal-title":"Astron. J."},{"issue":"8","key":"10.1016\/j.jconrel.2025.113616_bb0110","doi-asserted-by":"crossref","first-page":"10398","DOI":"10.1021\/acsami.2c19897","article-title":"Intracellular delivery of anti-Kirsten rat sarcoma antibodies mediated by polymeric micelles exerts strong","volume":"15","author":"Rafael","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.113616_bb0115","series-title":"The R Project for Statistical Computing","author":"Foundation, T. R","year":"2025"},{"issue":"12","key":"10.1016\/j.jconrel.2025.113616_bb0120","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMp1607591","article-title":"Toward a shared vision for cancer genomic data","volume":"375","author":"Grossman","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.113616_bb0125","series-title":"TCGA-GBM Project","year":"2025"},{"issue":"7","key":"10.1016\/j.jconrel.2025.113616_bb0130","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.jconrel.2025.113616_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14122904","article-title":"Nanomedicine penetration to tumor: challenges, and advanced strategies to tackle this issue","volume":"14","author":"Munir","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.jconrel.2025.113616_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/polym14122510","article-title":"A review of polymeric micelles and their applications","volume":"14","author":"Perumal","year":"2022","journal-title":"Polymers (Basel)"},{"issue":"7","key":"10.1016\/j.jconrel.2025.113616_bb0145","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2217\/nnm.12.163","article-title":"Taxol\u00ae-induced phosphatidylserine exposure and microvesicle formation in red blood cells is mediated by its vehicle Cremophor\u00ae EL","volume":"8","author":"Vader","year":"2013","journal-title":"Nanomedicine"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2025.113616_bb0150","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijpharm.2015.03.050","article-title":"Solid state formulations composed by amphiphilic polymers for delivery of proteins: characterization and stability","volume":"486","author":"Andrade","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113616_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12020185","article-title":"Intracellular delivery of anti-SMC2 antibodies against cancer stem cells","volume":"12","author":"Montero","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113616_bb0160","article-title":"Zileuton loaded in polymer micelles effectively reduce breast cancer circulating tumor cells and intratumoral cancer stem cells","volume":"24","author":"Gener","year":"2019","journal-title":"Nanomedicine"},{"issue":"7","key":"10.1016\/j.jconrel.2025.113616_bb0165","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.nano.2015.05.006","article-title":"Biological assessment of self-assembled polymeric micelles for pulmonary administration of insulin","volume":"11","author":"Andrade","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113616_bb0170","first-page":"346","article-title":"Hydrogel-based spheroid models of glioblastoma for drug screening applications","volume":"118","author":"Bruns","year":"2021","journal-title":"Mo. Med."},{"key":"10.1016\/j.jconrel.2025.113616_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2022.100116","article-title":"Characterization of glioblastoma spheroid models for drug screening and phototherapy assays","volume":"9","author":"Alves","year":"2023","journal-title":"OpenNano"},{"issue":"38","key":"10.1016\/j.jconrel.2025.113616_bb0180","doi-asserted-by":"crossref","first-page":"40998","DOI":"10.18632\/oncotarget.5701","article-title":"Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance","volume":"6","author":"Motaln","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2025.113616_bb0185","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.9559","article-title":"Ethyl pyruvate inhibits glioblastoma cells migration and invasion through modulation of NF-\u03baB and ERK-mediated EMT","volume":"8","author":"Huang","year":"2020","journal-title":"PeerJ"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113616_bb0190","doi-asserted-by":"crossref","first-page":"96","DOI":"10.35248\/0974-276X.19.12.502","article-title":"The quiescent metabolic phenotype of glioma stem cells","volume":"12","author":"Spehalski","year":"2019","journal-title":"J. Proteom. Bioinform."},{"key":"10.1016\/j.jconrel.2025.113616_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2023.132823","article-title":"The impact of PEG chain length on the in vivo tumor accumulation of self-assembled amphiphilic drug-PEG polymeric micelles","volume":"682","author":"Zheng","year":"2024","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.jconrel.2025.113616_bb0200","series-title":"Medicinal Chemistry of Chemotherapeutic Agents","first-page":"499","article-title":"Synthetic cytotoxic drugs as cancer chemotherapeutic agents","author":"Singh","year":"2023"},{"key":"10.1016\/j.jconrel.2025.113616_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102029","article-title":"How did lomustine become standard of care in recurrent glioblastoma?","volume":"87","author":"Weller","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jconrel.2025.113616_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110214","article-title":"The interactions of docetaxel with tumor microenvironment","volume":"119","author":"Gupta","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.jconrel.2025.113616_bb0215","first-page":"656","article-title":"Probing the new strategy for the oral formulations of taxanes: changing the method with the situation","volume":"19","author":"Wang","year":"2021","journal-title":"Chin. J. Nat. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113616_bb0220","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.annonc.2020.10.479","article-title":"Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial","volume":"32","author":"Shi","year":"2021","journal-title":"Ann. Oncol."},{"issue":"22","key":"10.1016\/j.jconrel.2025.113616_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212200","article-title":"3D cell culture systems: tumor application, advantages, and disadvantages","volume":"22","author":"Habanjar","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113616_bb0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.slasd.2023.03.006","article-title":"In vitro three-dimensional (3D) cell culture tools for spheroid and organoid models","volume":"28","author":"Lee","year":"2023","journal-title":"SLAS Discov."},{"issue":"10","key":"10.1016\/j.jconrel.2025.113616_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101328","article-title":"Cadherin expression and EMT: a focus on gliomas","volume":"9","author":"Noronha","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113616_bb0240","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1186\/s12885-017-3591-z","article-title":"Prognostic significance of E-cadherin and N-cadherin expression in gliomas","volume":"17","author":"Noh","year":"2017","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113616_bb0245","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11060-014-1459-5","article-title":"The overexpression of epithelial cell adhesion molecule (EpCAM) in glioma","volume":"119","author":"Chen","year":"2014","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2025.113616_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijso.2022.100527","article-title":"Epidermal growth factor receptor (EGFR) expression in high grade glioma and relationship with histopathologic findings, a cross sectional study","volume":"46","author":"Miratashi Yazdi","year":"2022","journal-title":"Int. J. Surg. Open"},{"issue":"38","key":"10.1016\/j.jconrel.2025.113616_bb0255","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012396","article-title":"Increased L1CAM (CD171) levels are associated with glioblastoma and metastatic brain tumors","volume":"97","author":"Wachowiak","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113616_bb0260","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/glia.10058","article-title":"L1 expressed by glioma cells promotes adhesion but not migration","volume":"38","author":"Senner","year":"2002","journal-title":"Glia"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113616_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/genes14061276","article-title":"Suppression of NANOG expression reduces drug resistance of cancer stem cells in glioblastoma","volume":"14","author":"Smith","year":"2023","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113616_bb0270","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1038\/s41598-019-39473-y","article-title":"Chimeric NANOG repressors inhibit glioblastoma growth in vivo in a context-dependent manner","volume":"9","author":"Kuciak","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113616_bb0275","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/neuonc\/noac157","article-title":"Oct4A palmitoylation modulates tumorigenicity and stemness in human glioblastoma cells","volume":"25","author":"Chen","year":"2023","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2025.113616_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111202","article-title":"The role of ALDH1A1 in glioblastoma proliferation and invasion","volume":"402","author":"Huang","year":"2024","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113616_bb0285","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11060-017-2422-z","article-title":"Expression and function of ABCG2 and XIAP in glioblastomas","volume":"133","author":"Emery","year":"2017","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2025.113616_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122594","article-title":"Soluplus\u00ae promotes efficient transport of meloxicam to the central nervous system via nasal administration","volume":"632","author":"Sipos","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113616_bb0295","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12987-024-00545-5","article-title":"Molecular determinants for brain targeting by peptides: a meta-analysis approach with experimental validation","volume":"21","author":"Cavaco","year":"2024","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jconrel.2025.113616_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124529","article-title":"Cancer cell membrane-modified Soluplus\u00ae micelles for gemcitabine delivery to pancreatic cancer using a prodrug approach","volume":"662","author":"Pereira-Silva","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113616_bb0305","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1021\/acs.molpharmaceut.2c00881","article-title":"Pterostilbene-loaded Soluplus\/Poloxamer 188 mixed micelles for protection against acetaminophen-induced acute liver injury","volume":"20","author":"Dong","year":"2023","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113616_bb0310","first-page":"3864","article-title":"Effect of docetaxel on the regulation of proliferation and apoptosis of human prostate cancer cells","volume":"19","author":"Yang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jconrel.2025.113616_bb0315","article-title":"A novel form of docetaxel polymeric micelles demonstrates anti-tumor and ascites-inhibitory activities in animal models as monotherapy or in combination with anti-angiogenic agents","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.jconrel.2025.113616_bb0320","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/jpp\/rgac048","article-title":"Docetaxel in combination with metformin enhances antitumour efficacy in metastatic breast carcinoma models: a promising cancer targeting based on PEGylated liposomes","volume":"74","author":"Vakili-Ghartavol","year":"2022","journal-title":"J. Pharm. Pharmacol."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113616_bb0325","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032671","article-title":"Treatment outcomes with radium-223 in docetaxel-na\u00efve versus docetaxel-treated metastatic castration-resistant prostate cancer patients: real-world evidence from Taiwan","volume":"102","author":"Chiang","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113616_bb0330","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jtho.2022.09.217","article-title":"Tislelizumab versus docetaxel in patients with previously treated advanced NSCLC (RATIONALE-303): a phase 3, open-label, randomized controlled trial","volume":"18","author":"Zhou","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.jconrel.2025.113616_bb0335","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/cells10030484","article-title":"The many facets of therapy resistance and tumor recurrence in glioblastoma","volume":"10","author":"Goenka","year":"2021","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.jconrel.2025.113616_bb0340","first-page":"25","article-title":"Recurrent glioblastoma-molecular underpinnings and evolving treatment paradigms","author":"Chang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113616_bb0345","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13287-021-02231-x","article-title":"Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives","volume":"12","author":"Alves","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"10.1016\/j.jconrel.2025.113616_bb0350","first-page":"676","article-title":"Molecular mechanisms of docetaxel resistance in prostate cancer","volume":"3","author":"Sekino","year":"2020","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.jconrel.2025.113616_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124623","article-title":"Prostate cancer chemotherapy by intratumoral administration of docetaxel-mesoporous silica nanomedicines","volume":"664","author":"Rivero-Buceta","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113616_bb0360","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2174\/1568009618666180703154233","article-title":"Polyploid giant cancer cells (PGCCs): the evil roots of cancer","volume":"19","author":"Chen","year":"2019","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.jconrel.2025.113616_bb0365","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2147\/IJN.S121881","article-title":"Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile","volume":"12","author":"Rafiei","year":"2017","journal-title":"Int. J. Nanomedicine"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113616_bb0370","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1039\/D1CB00089F","article-title":"Biodegradable self-assembly micelles significantly enhanced the solubility, biological stability and","volume":"2","author":"Fang","year":"2021","journal-title":"RSC Chem. Biol."},{"key":"10.1016\/j.jconrel.2025.113616_bb0375","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.toxrep.2024.04.001","article-title":"Maximum tolerated dose and toxicity evaluation of orally administered docetaxel granule in mice","volume":"12","author":"Dong","year":"2024","journal-title":"Toxicol. Rep."},{"issue":"24","key":"10.1016\/j.jconrel.2025.113616_bb0380","article-title":"Effects of docetaxel injection and docetaxel micelles on the intestinal barrier and intestinal microbiota","volume":"8","author":"Liu","year":"2021","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"4","key":"10.1016\/j.jconrel.2025.113616_bb0385","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2174\/1567201814666170621113637","article-title":"Mixed micelles as nano polymer therapeutics of docetaxel: increased in vitro cytotoxicity and decreased in vivo toxicity","volume":"15","author":"Manjappa","year":"2018","journal-title":"Curr. Drug Deliv."},{"issue":"10","key":"10.1016\/j.jconrel.2025.113616_bb0390","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/aps.2018.16","article-title":"Combined treatment with apatinib and docetaxel in A549 xenograft mice and its cellular pharmacokinetic basis","volume":"39","author":"Feng","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113616_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100185","article-title":"Cancer and hepatic steatosis","volume":"6","author":"Paternostro","year":"2021","journal-title":"ESMO Open"}],"updated-by":[{"DOI":"10.1016\/j.jconrel.2025.114479","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000}},{"DOI":"10.1016\/j.jconrel.2025.114479","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000}}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925002330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925002330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:01:49Z","timestamp":1769220109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925002330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":79,"alternative-id":["S0168365925002330"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113616","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical evaluation of several polymeric micelles identifies Soluplus\u00ae-docetaxel as the most effective candidate in multiple glioblastoma models","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113616","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113616"}}